I agree, this should not be a controversial decision for them to make. It is the perfect candidate for their 150 day approval goal. A safe, effective treatment for an orphan designated candidate for a disease that has seen no improvement to SOC for almost 20 years.
NICE approval might be a little longer given the cost and potential improvements EDEN would bring.
Market Data 
Markets 
AI
